WASHINGTON (Reuters) – Consumers, insurance companies and the federal government spend an extra $3.5 billion for prescription drugs every year because brand-name companies pay generic producers to stay out of the market, the head of the U.S. Federal Trade Commission said on Tuesday. FTC chief Jon Leibowitz urged Congress to pass legislation, now pending in [...]
Continue reading...
Tuesday, June 23, 2009
0 Comments